New Patient Appointment or 214-645-8300

MedBlog

All Cancer

Cancer

When Cancer Fights Back

Breast cancer can stay in remission for many years, thanks to effective drugs like tamoxifen. But sometimes breast cancer reappears. A new drug under study at UT Southwestern holds promise for people who are facing recurrent breast cancer. Read more.

Cancer

‘It Saved My Life’

Cancer

How a lymphoma clinic can lead to more accurate, specialized care

Lymphoma is one the most common cancers in the United States and sometimes can be difficult to diagnose. Discover why Syed Rizvi, M.D., says patients receive accurate, specialized care from a team approach at UT Southwestern’s lymphoma clinic.

Cancer

Skin lymphoma: Rare cancer, strange symptoms, effective treatments

A rare form of lymphoma – skin lymphoma – can resemble rashes or even mushrooms on the skin. Most cases are very treatable with care from a lymphoma expert. Learn more.

Cancer

5 myths about skin cancer prevention – and some truths

Is sunscreen enough to prevent skin cancer? Is our skin protected behind window glass? In this week’s blog, Jennifer Gill, M.D., Ph.D., clears up five misconceptions about skin cancer prevention, and then offers up some truths.

Cancer

5 Things That Can Help You Fight Cancer

Here’s a look at a combination of smart health habits and technology that just might give you an edge.

Cancer

A Targeted Attack

This one-two drug combo punch may help in the fight against lung cancer.

Cancer

In My Own Words

The diagnosis of a rare disease requires a highly specialized, skilled team of medical professionals on your side.

Cancer

Q&A: Advances in Brain Tumor Treatment

Doctors and researchers are making strides every day in the fight against brain cancer. Read on to learn about some of the new developments underway at UT Southwestern.

Cancer

What new research on Herceptin could mean for breast cancer patients

A 2018 study suggests that half the dosage of breast cancer drug Herceptin is just as effective as the one-year dose and carries fewer side effects for those with HER-2 positive breast cancer. But Thomas Froehlich, M.D., says it’s too soon to change treatment recommendations. Learn more.